Editorial Podcasts

Episode 62: The Future of Pharma’s Supply Chain

August 06, 2020

Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies can prepare for that.

Episode 61: Preparing for Virtual High-Stakes Meetings

July 23, 2020

Pharmaceutical Executive

Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory presentations and keynote addresses, in the wake of COVID-19.

Episode 60: Leading With Compassion

July 09, 2020

Pharmaceutical Executive

Tim Walbert, CEO of Horizon Therapeutics, shares his unique perspective on managing a company through COVID-19, in light of the fact that he himself is immunocompromised.

Episode 59: Using Tau to Target Alzheimer’s

June 25, 2020

Pharmaceutical Executive

Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.

Episode 58: Understanding FDA’s Gene Therapy Guidelines

June 11, 2020

Pharmaceutical Executive

Dr. Jonathan Gertler, CEO of Back Bay Life Science Advisors, and Dr. Stephan Gauldie, Senior Vice President of Back Bay, talk about the new guidelines set forth by FDA in regard to gene therapy, and what those new parameters mean for pharma and biotech.

Episode 57: Planning for Pharma’s New Normal

May 28, 2020

Pharmaceutical Executive

Senior Editor, Elaine Quilici interviews Pratap Khedkar, managing principal of ZS Associates. Pratap talks about pharma’s scenario planning amid COVID-19 as it looks to settle into a new normal.

Episode 56: Killing Cancer Through Direct Injection

May 14, 2020

Pharmaceutical Executive

Lew Bender, founder of Intensity Therapeutics and the inventor of Intensity’s DfuseRx platform technology, discusses the technology that allows the company’s therapeutic products to be injected directly into solid tumors, this innovative process successfully kills tumors and activates an immune response to shut down cancer cells throughout the body.

Episode 55: Developing a Maternal RSV Vaccine

April 30, 2020

Pharmaceutical Executive

Kathrin Jansen, Senior Vice President and Head of Vaccine Research and Development at Pfizer, talks about the challenges of creating a new maternal vaccine for respiratory syncytial virus, also known as RSV, currently being administered to pregnant women in trials, in the hopes of protecting their infants.

Episode 54: Taking Advantage of Digital Marketing

April 16, 2020

Pharmaceutical Executive

Chris Paquette, DeepIntent co-founder and CEO, talks about the evolution of digital marketing in pharma, specifically, how to approach data and technology usage in a privacy-first world.

Episode 53: Fabulous Pharma Females

April 02, 2020

Pharmaceutical Executive

Barbara Ryan, founder of Barbara Ryan Advisors, a member of PharmExec’s editorial advisory board, and the founder of Fabulous Pharma Females discusses the strong community she’s built providing women the opportunity to connect with each other and reinforce their shared commitment to one another.